← Leaderboards
Rolf F Renne
University Of Florida
$15,821,379
Attributed
$15,821,379
Total exposure
18
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.5M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$28,709,587 · 19
By mechanism
P01$17,788,163 · 10
R01$8,132,759 · 3
P30$1,024,978 · 1
RC2$1,000,000 · 1
R21$678,253 · 2
T32$67,434 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Florida
Same institution · by research overlap
- Erik K Flemington$23,678,004
- Zsolt Toth$3,909,941
- Scott A. Tibbetts$9,656,998
- Bernadett Papp$1,793,743
- Seung Jin Jang$86,096
Others in their field
Top investigators on “Human Herpesvirus 8”
- David Heimbrook · Leidos Biomedical Research, Inc.$188,989,000
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Leonard Freedman · Leidos Biomedical Research, Inc.$65,587,215
- Jae U Jung · Cleveland Clinic Lerner Com-Cwru$44,754,023
- Scott W Wong · Oregon Health And Science University$28,229,656
- Blossom A Damania · University Of North Carolina Chapel Hill$27,475,432
Research focus
Human Herpesvirus 8ViralMalignant NeoplasmsBiologyAcquired Immunodeficiency SyndromeHerpesviridaeProgramsUntranslated RnaMicrornasGene ExpressionTumorigenesisCellsRecombinantsGammaherpesvirusHuman Herpesvirus 4VirusPathogenesisProtocols DocumentationPhenotypeGenesPathway InteractionsCell LineBaseTranscriptome Sequencing
Grant awards (84)
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies$1,501,823
P01 · FY2025 · CA · contact PI
"Core A" Administrative Core$214,547
P01 · FY2025 · CA · contact PI
"Project 1" KSHV short and long noncoding RNAs and alteration of host IncRNA expression$214,547
P01 · FY2025 · CA · contact PI
"Core C" Recombinant Virus Core$214,545
P01 · FY2025 · CA · contact PI
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies$1,501,823
P01 · FY2024 · CA · contact PI
"Project 1" KSHV short and long noncoding RNAs and alteration of host IncRNA expression$286,778
P01 · FY2024 · CA · contact PI
"Core C" Recombinant Virus Core$139,481
P01 · FY2024 · CA · contact PI
"Core A" Administrative Core$119,029
P01 · FY2024 · CA · contact PI
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies$77,664
P01 · FY2024 · CA · contact PI
"Project 1" KSHV short and long noncoding RNAs and alteration of host IncRNA expression$77,664
P01 · FY2024 · CA · contact PI
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies$76,753
P01 · FY2024 · CA · contact PI
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies$1,505,722
P01 · FY2023 · CA · contact PI
"Project 1" KSHV short and long noncoding RNAs and alteration of host IncRNA expression$292,992
P01 · FY2023 · CA · contact PI
"Core C" Recombinant Virus Core$132,600
P01 · FY2023 · CA · contact PI
"Core A" Administrative Core$110,330
P01 · FY2023 · CA · contact PI
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies$46,808
P01 · FY2023 · CA · contact PI
"Project 1" KSHV short and long noncoding RNAs and alteration of host IncRNA expression$42,995
P01 · FY2023 · CA · contact PI
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies$42,995
P01 · FY2023 · CA · contact PI
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies$1,569,513
P01 · FY2022 · CA · contact PI
The Role of H3.3 histone variant in the pathogenesis of oral Kaposi's Sarcoma$355,332
R01 · FY2022 · DE · contact PI
"Project 1" KSHV short and long noncoding RNAs and alteration of host IncRNA expression$293,029
P01 · FY2022 · CA · contact PI
"Core C" Recombinant Virus Core$124,757
P01 · FY2022 · CA · contact PI
"Core A" Administrative Core$110,009
P01 · FY2022 · CA · contact PI
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies$1,312,028
P01 · FY2021 · CA · contact PI
The Role of H3.3 histone variant in the pathogenesis of oral Kaposi's Sarcoma$355,658
R01 · FY2021 · DE · contact PI
"Project 1" KSHV-encoded Inc RNAs and alteration of host IncRNA expression$281,327
P01 · FY2021 · CA · contact PI
"Core C" Recombinant Virus Core$126,723
P01 · FY2021 · CA · contact PI
"Core A" Administrative Core$108,206
P01 · FY2021 · CA · contact PI
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies$1,312,028
P01 · FY2020 · CA · contact PI
The Role of H3.3 histone variant in the pathogenesis of oral Kaposi's Sarcoma$355,969
R01 · FY2020 · DE · contact PI
"Project 1" KSHV-encoded Inc RNAs and alteration of host IncRNA expression$281,327
P01 · FY2020 · CA · contact PI
"Core C" Recombinant Virus Core$126,723
P01 · FY2020 · CA · contact PI
"Core A" Administrative Core$108,206
P01 · FY2020 · CA · contact PI
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies$1,272,666
P01 · FY2019 · CA · contact PI
The Role of H3.3 histone variant in the pathogenesis of oral Kaposi's Sarcoma$356,266
R01 · FY2019 · DE · contact PI
"Project 1" KSHV-encoded Inc RNAs and alteration of host IncRNA expression$272,889
P01 · FY2019 · CA · contact PI
"Core C" Recombinant Virus Core$122,919
P01 · FY2019 · CA · contact PI
"Core A" Administrative Core$104,959
P01 · FY2019 · CA · contact PI
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies$1,312,028
P01 · FY2018 · CA · contact PI
The Role of H3.3 histone variant in the pathogenesis of oral Kaposi's Sarcoma$356,547
R01 · FY2018 · DE · contact PI
"Project 1" KSHV-encoded Inc RNAs and alteration of host IncRNA expression$288,290
P01 · FY2018 · CA · contact PI
"Core C" Recombinant Virus Core$116,507
P01 · FY2018 · CA · contact PI
"Core A" Administrative Core$95,932
P01 · FY2018 · CA · contact PI
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies$1,356,357
P01 · FY2017 · CA · contact PI
Studying the role of KSHV-encoded miRNAs$301,913
R01 · FY2017 · CA · contact PI
"Project 1" KSHV-encoded Inc RNAs and alteration of host IncRNA expression$241,215
P01 · FY2017 · CA · contact PI
"Core C" Recombinant Virus Core$131,887
P01 · FY2017 · CA · contact PI
"Core A" Administrative Core$119,542
P01 · FY2017 · CA · contact PI
Studying the role of KSHV-encoded miRNAs$301,913
R01 · FY2016 · CA · contact PI
Studying the role of KSHV-encoded miRNAs$301,913
R01 · FY2015 · CA · contact PI
LANA and Cellular Gene Expression$230,935
R01 · FY2015 · CA · contact PI
Histone variant H3.3 and KSHV LANA in the pathogenesis of oral Kaposi's sarcoma$186,016
R21 · FY2015 · DE · contact PI
Studying the role of KSHV-encoded miRNAs$292,042
R01 · FY2014 · CA · contact PI
LANA and Cellular Gene Expression$224,007
R01 · FY2014 · CA · contact PI
Histone variant H3.3 and KSHV LANA in the pathogenesis of oral Kaposi's sarcoma$223,587
R21 · FY2014 · DE · contact PI
Studying the role of KSHV-encoded miRNAs$299,900
R01 · FY2013 · CA · contact PI
LANA and Cellular Gene Expression$217,079
R01 · FY2013 · CA · contact PI
Studying the role of KSHV-encoded microRNAs$286,093
R01 · FY2012 · CA · contact PI
LANA and Cellular Gene Expression$230,935
R01 · FY2012 · CA · contact PI
Studying the role of KSHV-encoded microRNAs$287,237
R01 · FY2011 · CA · contact PI
LANA and Cellular Gene Expression$230,935
R01 · FY2011 · CA · contact PI
Building a recombinant Herpesvirus core laboratory to systematically analyze the$500,000
RC2 · FY2010 · CA · contact PI
Studying the role of KSHV-encoded microRNAs$297,147
R01 · FY2010 · CA · contact PI
Building a recombinant Herpesvirus core laboratory to systematically analyze the$500,000
RC2 · FY2009 · CA · contact PI
Studying the role of KSHV-encoded microRNAs$412,258
R01 · FY2009 · CA · contact PI
Biodefense and Emerging Infectious Diseases (BEID)$67,434
T32 · FY2009 · AI · contact PI
12th International Workshop on KSHV and Related Agents$18,000
R13 · FY2009 · CA · contact PI
Studying the role of KSHV-encoded microRNAs$413,034
R01 · FY2008 · CA · contact PI
CORE--Molecular Virology & Gene Expression Core$259,759
P30 · FY2008 · AI · contact PI
Lana and Cellular Gene Expression in Kaposis Sarcoma$226,694
R01 · FY2008 · CA · contact PI
CORE--Molecular Virology & Gene Expression Core$254,468
P30 · FY2007 · AI · contact PI
Lana and Cellular Gene Expression in Kaposis Sarcoma$226,694
R01 · FY2007 · CA · contact PI
Lana and Cellular Gene Expression in Kaposis Sarcoma$233,465
R01 · FY2006 · CA · contact PI
CORE--Molecular Virology & Gene Expression Core$175,631
P30 · FY2006 · AI · contact PI
Lana and Cellular Gene Expression in Kaposis Sarcoma$239,084
R01 · FY2005 · CA
CORE--Molecular Virology &Gene Expression Core$171,199
P30 · FY2005 · AI
Targeting LANA Function to Develop KSHV Antivirals$130,950
R21 · FY2005 · CA
Lana and Cellular Gene Expression in Kaposis Sarcoma$239,084
R01 · FY2004 · CA
CORE--Molecular Virology &Gene Expression Core$163,921
P30 · FY2004 · AI
Targeting LANA Function to Develop KSHV Antivirals$137,700
R21 · FY2004 · CA
LANA AND CELLULAR GENE EXPRESSION IN KAPOSIS SARCOMA$206,550
R01 · FY2003 · CA
LANA AND CELLULAR GENE EXPRESSION IN KAPOSIS SARCOMA$206,550
R01 · FY2002 · CA
LANA AND CELLULAR GENE EXPRESSION IN KAPOSIS SARCOMA$240,975
R01 · FY2001 · CA
LANA AND CELLULAR GENE EXPRESSION IN KAPOSIS SARCOMA$206,550
R01 · FY2000 · CA